By using GEPIA to analyze the correlation between GLI1 and cyclin Ds, CDKs, and GSK3α/β, we found that the cyclin D, CDK6, and GSK3α/β levels were positively correlated with GLI1 in AML patients (Figs. 2D and S2A). Here, GLI1 is linked to acute myeloid leukemia.